Obexelimab and the Promise of Nondepleting B-Cell Therapy in IgG4-Related Disease

New England Journal of Medicine 2026

View at publisher

Authors: T Dörner

DOI: 10.1056/nejme2605617

Cited by: 1

References: 8

Fields of Study & Subjects

IgG4-Related and Inflammatory Diseases Immunodeficiency and Autoimmune Disorders Neuroendocrine Tumor Research Advances

References 8